Tag: National Heart Lung and Blood Institute


UTHSC Researchers Awarded $2.4 Million for Study Prioritizing the Role of Cholesterol in Brain Artery Health

|

Alex Dopico, MD, PhD, professor and Van Vleet Chair of Excellence in the Department of Pharmacology, Addiction Science, and Toxicology, and Anna Bukiya, PhD, associate professor in the Department of Pharmacology, Addiction Science, and Toxicology, have been awarded $2.4 million from the National Heart, Lung, and Blood Institute (NHLBI) to explore how cholesterol interacts with… Read More


Alex Dopico, MD, PhD, of UTHSC Investigating Mechanisms and Novel Drug Therapies to Control Vascular Function

|

Alex Dopico, MD, PhD, University Distinguished Professor and chair of the Department of Pharmacology at the University of Tennessee Health Science Center (UTHSC), has been awarded over $2.4 million from the National Heart, Lung, and Blood Institute (NHLBI) to explore the mechanisms by which our bodies regulate arterial diameter and thus develop new drug therapies… Read More


Investigators at UTHSC Played Key Role in Study Prompting New Blood Pressure Guidelines

|

Researchers at the University of Tennessee Health Science Center and the Memphis Veterans Affairs Medical Center played a significant role in collecting data that resulted in the new guidelines announced last week for the prevention, detection, evaluation, and management of high blood pressure. The first comprehensive new high blood pressure guidelines in more than a decade… Read More